video corpo

women rapid diagnostic test / for cancers / for tumor markers / tissue
Xpert® Breast Cancer STRAT4



  • Patient type:

    for women

  • Applications:

    for cancers

  • Tested parameter:

    for tumor markers

  • Sample type:


  • Analysis mode:

    for real-time PCR


Xpert® Breast Cancer STRAT4
Standardized breast cancer ER/PGR/HER2/Ki-67 mRNA biomarker assessment in less than two hours
The Solution
Xpert® Breast Cancer STRAT4 paves the way for a standardized, precise and reliable ER/PGR/HER2/Ki-67 mRNA assessment in less than 2 hours

Xpert Breast Cancer STRAT4 delivers semi-quantitative determination of ER/PGR/HER2/Ki-67 mRNA levels in FFPE invasive breast cancer sections
CYFIP1* reference gene is used for sample normalization
Three controls included in each test
Software report allows for objective and easy result interpretation
External FFPE controls# available for identifying errors, shifts, trends and operator variabilitiesThe Impact
Xpert Breast Cancer STRAT4 standardizes reproducible ER/PGR/HER2/Ki-67 assessment

Clear and accurate results empower oncologists.
Enables flexibility, simplicity and random access for a streamlined workflow 24/7.
Easy and fast test implementation.
Internal controls meet quality management requirements.
Robust test and workflow that doesn’t require a PCR laboratory.